The investment package was launched in collaboration with the Ministry of Health and the Public Authority for Special Economic Zones and Free Zones.
Under the new structure, hospitals and clinics previously operating as NMC Oman will now operate under the Numa Health brand, while EMC will continue as a dedicated sub-brand focused on dermatology and aesthetic medicine.
The platform now enables the secure exchange of approvals, billing, and settlements among pharmacies, insurers, and healthcare providers, reducing reliance on manual paperwork by up to 98% in certain processes.
The newly introduced National Strategy for Vector Surveillance reflects Oman’s commitment to strengthening health security in line with Oman Vision 2040.
Neuralink’s clinical programme has recorded notable early milestones, including reports that its first human participant successfully operated a computer and typed using neural signals alone.
The newly introduced National Strategy for Vector Surveillance reflects Oman’s commitment to strengthening health security in line with Oman Vision 2040.
The investment comes as Oman accelerates the modernization of its healthcare infrastructure through public-private collaboration and increased adoption of advanced medical technologies.
The opening of Mahout Hospital reflects Oman’s ongoing strategy to improve health security and ensure that all citizens have access to reliable care regardless of location.
Spread across approximately 20,000 square metres, the plant is equipped with automated production lines and advanced quality control laboratories built to international pharmaceutical standards.
This initiative directly supports Oman Vision 2040, the national strategic framework that prioritizes industrial diversification and self-sufficiency in essential sectors.